Bank of Montreal’s consistently bullish chief investment strategist isn’t blinking as U.S. President Donald Trump’s tariff ...

(Bloomberg) -- Bank of Montreal and Bank of Nova Scotia kicked off Canadian bank earnings season with strong results from their capital-markets divisions amid an increase in trading activity.

Dyne Therapeutics (NASDAQ:DYN) traded higher in the premarket on Wednesday after BMO Capital Markets launched its coverage with an Outperform recommendation and a $50 per share target, citing the ...

BMO Capital Markets. "As the industry evolves, our priority is providing exceptional service to our clients while delivering more integrated and innovative solutions to grow our market leading ...

Evertz Technologies (TSE:ET – Free Report) had its price target reduced by BMO Capital Markets from C$15.00 to C$13.50 in a research report report published on Thursday,BayStreet.CA reports.

GE Vernova (NYSE:GEV – Free Report) had its price objective lowered by BMO Capital Markets from $471.00 to $420.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has ...

The S&P 500 has never lost ground in the back half of the year after advancing between 10% and 15% in the first six months, according to BMO Capital Markets, citing data since 1950. The Montreal ...

BMO Capital initiated coverage of Rocket Pharmaceuticals (RCKT) with an Outperform rating and $50 price target The gene therapy company has “two major differences from the typical gene therapy ...

Focus on 42 stocks with solid dividend growth as inflation runs rampant Belski and his colleagues at BMO Capital Markets have nine investing strategy portfolios that can serve as models for investors.

BMO Capital analyst Daniel Jester lowered the firm’s price target on Workiva (WK) to $108 from $120 and keeps an Outperform rating on the shares. The company finished the year on a generally ...